Assignee

Axsome Therapeutics, Inc.

Patents = 127

Trademarks = 20

Forward Citations = 5,024

where 'Filed Patents' based on already Granted Patents

where 'Inventors Filed' based on already Granted Patents

4 inventors (with patents filed for the assignee):

Axsome Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on developing novel therapies to improve the lives of patients with neurological disorders. The company's product pipeline is designed to address a range of central nervous system (CNS) conditions, such as major depressive disorder, treatment-resistant depression, migraine, and Alzheimer's disease. With a commitment to innovation and clinical excellence, Axsome Therapeutics aims to bring transformative treatments to patients in need.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com